Report Overview

EU Type I Diabetes Mellitus Treatment market stood at XX billion in 2019 and expected to reach XX billion in 2028 at a CAGR of XX% during the forecast period

Type I Diabetes Mellitus is an autoimmune condition. It happens when y our body attacks the pancreas with antibodies. The organ is damaged and doesn't make insulin. Many of the health problems that can come with type 1 happen because of damage to tiny blood vessels in the eyes(called diabetic retinopathy), nerves (diabetic retinopathy), and kidneys(diabetic nephropathy). People with type 1 also have a higher risk of heart disease and stroke. Treatment for Diabetes Type I involves injecting insulin into the fatty tissue just under the skin. Approximately 2 million people are estimated to suffer from Type-1 diabetes in the EU. The prevalence of diabetes is growing among all ages in the EU, which may be attributed to the growing obese population, along with unhealthy diets and sedentary lifestyles of people



Market Growth Drivers

The type I diabetes mellitus treatment market is anticipated to grow significantly owing to the availability of insulin as the major mode of treatment, which is likely to contribute to the growth of the market. The rising prevalence of the disease contributing to the increasing patient pool aids in the type I diabetes mellitus treatment market growth